CytoMed Therapeutics Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About CytoMed Therapeutics Ltd
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy CytoMed Therapeutics Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for CytoMed Therapeutics Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for CytoMed Therapeutics Ltd is GDTC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
CytoMed Therapeutics Ltd has its primary listing on NASDAQ (Small cap). You can trade CytoMed Therapeutics Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, CytoMed Therapeutics Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include CytoMed Therapeutics Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like CytoMed Therapeutics Ltd.